PRG Science & Technology Co., Ltd.   Report issue

For profit Phase 1
Founded: Busan Korea, Republic of (1995)

Organization Overview

First Clinical Trial
2020
NCT04512963
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

PRG Science & Technology Co., Ltd.

Active Ingredients

Drugs in Phase 1 Trials (1)

progerinin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Progeria (Phase 1)

Syndrome (Phase 1)

Werner Syndrome (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1